CSAN logo

Cosan S.A. (CSAN) EBITDA

annual EBITDA:

$1.08B-$1.75B(-61.97%)
December 31, 2024

Summary

  • As of today (August 18, 2025), CSAN annual EBITDA is $1.08 billion, with the most recent change of -$1.75 billion (-61.97%) on December 31, 2024.
  • During the last 3 years, CSAN annual EBITDA has fallen by -$1.27 billion (-54.22%).
  • CSAN annual EBITDA is now -65.67% below its all-time high of $3.13 billion, reached on March 31, 2012.

Performance

CSAN EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCSANincome statement metrics

quarterly EBITDA:

$605.42M+$178.61M(+41.85%)
June 1, 2025

Summary

  • As of today (August 18, 2025), CSAN quarterly EBITDA is $605.42 million, with the most recent change of +$178.61 million (+41.85%) on June 1, 2025.
  • Over the past year, CSAN quarterly EBITDA has increased by +$371.12 million (+158.39%).
  • CSAN quarterly EBITDA is now -4.55% below its all-time high of $634.30 million, reached on September 30, 2023.

Performance

CSAN quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCSANincome statement metrics

TTM EBITDA:

$2.11B+$371.12M(+21.29%)
June 1, 2025

Summary

  • As of today (August 18, 2025), CSAN TTM EBITDA is $2.11 billion, with the most recent change of +$371.12 million (+21.29%) on June 1, 2025.
  • Over the past year, CSAN TTM EBITDA has increased by +$239.20 million (+12.76%).
  • CSAN TTM EBITDA is now -3.73% below its all-time high of $2.20 billion, reached on March 31, 2024.

Performance

CSAN TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCSANincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

CSAN EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-62.0%+158.4%+12.8%
3 y3 years-54.2%+29.3%+53.8%
5 y5 years-51.1%+1001.1%+259.5%

CSAN EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-62.0%at low-4.5%+158.4%-3.7%+53.8%
5 y5-year-62.0%at low-4.5%+1001.1%-3.7%+349.6%
alltimeall time-65.7%+7714.2%-4.5%>+9999.0%-3.7%+7794.0%

CSAN EBITDA History

DateAnnualQuarterlyTTM
Jun 2025
-
$605.42M(+41.8%)
$2.11B(+21.3%)
Mar 2025
-
$426.81M(-7.6%)
$1.74B(-8.0%)
Dec 2024
$1.08B(-62.0%)
$461.94M(-25.5%)
$1.89B(+1.8%)
Sep 2024
-
$620.31M(+164.7%)
$1.86B(-0.7%)
Jun 2024
-
$234.30M(-59.5%)
$1.88B(-14.6%)
Mar 2024
-
$578.15M(+34.9%)
$2.20B(+5.6%)
Dec 2023
$2.83B(+31.0%)
$428.52M(-32.4%)
$2.08B(+3.5%)
Sep 2023
-
$634.30M(+14.2%)
$2.01B(+9.0%)
Jun 2023
-
$555.38M(+20.4%)
$1.84B(+5.0%)
Mar 2023
-
$461.23M(+28.6%)
$1.76B(+6.3%)
Dec 2022
$2.16B(-8.1%)
$358.52M(-23.5%)
$1.65B(+9.9%)
Sep 2022
-
$468.58M(+0.1%)
$1.50B(+9.3%)
Jun 2022
-
$468.17M(+31.2%)
$1.37B(+10.7%)
Mar 2022
-
$356.92M(+70.5%)
$1.24B(+14.2%)
Dec 2021
$2.35B(+63.5%)
$209.30M(-38.5%)
$1.09B(+9.6%)
Sep 2021
-
$340.46M(+1.4%)
$992.61M(+24.8%)
Jun 2021
-
$335.71M(+65.6%)
$795.60M(+54.5%)
Mar 2021
-
$202.74M(+78.3%)
$514.88M(+9.5%)
Dec 2020
$1.44B(-34.8%)
$113.69M(-20.8%)
$470.33M(-4.7%)
Sep 2020
-
$143.46M(+160.9%)
$493.69M(-16.1%)
Jun 2020
-
$54.99M(-65.2%)
$588.19M(-18.3%)
Mar 2020
-
$158.20M(+15.4%)
$720.21M(+5.1%)
Dec 2019
$2.20B(+106.1%)
$137.04M(-42.4%)
$685.57M(+7.9%)
Sep 2019
-
$237.96M(+27.3%)
$635.24M(+25.7%)
Jun 2019
-
$187.01M(+51.4%)
$505.45M(+20.9%)
Mar 2019
-
$123.56M(+42.5%)
$418.04M(+0.4%)
Dec 2018
$1.07B(-4.8%)
$86.71M(-19.8%)
$416.43M(-1.4%)
Sep 2018
-
$108.18M(+8.6%)
$422.33M(-8.9%)
Jun 2018
-
$99.59M(-18.3%)
$463.56M(-3.5%)
Mar 2018
-
$121.95M(+31.7%)
$480.51M(+4.4%)
Dec 2017
$1.12B(+14.3%)
$92.61M(-38.0%)
$460.14M(-0.8%)
Sep 2017
-
$149.41M(+28.2%)
$463.90M(+0.5%)
Jun 2017
-
$116.54M(+14.7%)
$461.80M(-10.7%)
Mar 2017
-
$101.58M(+5.4%)
$517.10M(-3.6%)
Dec 2016
$981.42M(+39.3%)
$96.37M(-34.6%)
$536.64M(-1.3%)
Sep 2016
-
$147.31M(-14.3%)
$543.48M(+7.9%)
Jun 2016
-
$171.84M(+41.9%)
$503.76M(+2.9%)
Mar 2016
-
$121.12M(+17.4%)
$489.35M(+6.1%)
Dec 2015
$704.79M(-13.4%)
$103.21M(-4.1%)
$461.02M(-2.9%)
Sep 2015
-
$107.59M(-31.7%)
$475.00M(-11.9%)
Jun 2015
-
$157.43M(+69.7%)
$539.19M(-6.1%)
Mar 2015
-
$92.79M(-20.8%)
$574.23M(-9.3%)
DateAnnualQuarterlyTTM
Dec 2014
$813.61M(+22.5%)
$117.20M(-31.8%)
$633.28M(-11.0%)
Sep 2014
-
$171.78M(-10.8%)
$711.33M(-5.2%)
Jun 2014
-
$192.47M(+26.8%)
$750.49M(-1.9%)
Mar 2014
-
$151.84M(-22.2%)
$765.13M(-27.0%)
Dec 2013
$663.99M(-78.8%)
$195.25M(-7.4%)
$1.05B(+22.9%)
Sep 2013
-
$210.94M(+1.8%)
$853.15M(+32.8%)
Jun 2013
-
$207.11M(-52.4%)
$642.21M(+47.6%)
Mar 2013
-
$435.10M(+194.5%)
$435.10M(-61.5%)
Mar 2012
$3.13B(+102.1%)
$147.75M(-45.2%)
$1.13B(-29.1%)
Dec 2011
-
$269.60M(-38.8%)
$1.59B(-2.9%)
Sep 2011
-
$440.81M(+62.3%)
$1.64B(-2.8%)
Jun 2011
-
$271.53M(-55.5%)
$1.69B(+6.8%)
Mar 2011
$1.55B(+110.5%)
$610.29M(+91.9%)
$1.58B(+27.4%)
Dec 2010
-
$317.99M(-34.8%)
$1.24B(+15.2%)
Sep 2010
-
$487.58M(+198.0%)
$1.08B(+37.9%)
Jun 2010
-
$163.63M(-39.6%)
$780.48M(+6.3%)
Mar 2010
$736.35M(+104.0%)
-
-
Mar 2010
-
$270.84M(+75.6%)
$734.56M(+58.4%)
Dec 2009
-
$154.27M(-19.5%)
$463.72M(+49.9%)
Sep 2009
-
$191.74M(+62.9%)
$309.44M(+162.9%)
Jun 2009
-
$117.70M(+337.4%)
$117.70M(+24.7%)
Mar 2009
$361.03M(+2523.2%)
-
-
Apr 2008
$13.76M(-97.3%)
-
-
Apr 2008
-
$26.91M(+3705.9%)
$94.42M(-36.8%)
Jan 2008
-
$707.00K(-98.3%)
$149.49M(-37.9%)
Oct 2007
-
$41.20M(+60.9%)
$240.61M(-6.3%)
Jul 2007
-
$25.61M(-68.8%)
$256.85M(-32.5%)
Apr 2007
$505.12M(+391.1%)
-
-
Apr 2007
-
$81.98M(-10.7%)
$380.56M(+2.0%)
Jan 2007
-
$91.83M(+59.9%)
$373.08M(+17.3%)
Oct 2006
-
$57.44M(-61.5%)
$318.08M(+3.3%)
Jul 2006
-
$149.32M(+100.4%)
$307.82M(+51.9%)
Apr 2006
$102.85M(-1.4%)
-
-
Apr 2006
-
$74.49M(+102.3%)
$202.70M(+58.1%)
Jan 2006
-
$36.83M(-21.9%)
$128.20M(+6.5%)
Oct 2005
-
$47.17M(+6.7%)
$120.43M(+5.7%)
Jul 2005
-
$44.20M(+52.1%)
$113.99M(+18.0%)
Apr 2005
$104.31M(+19.7%)
-
-
Jan 2005
-
$29.06M(-28.7%)
$96.58M(+43.0%)
Oct 2004
-
$40.73M(+52.1%)
$67.52M(+152.1%)
Jul 2004
-
$26.79M
$26.79M
Apr 2004
$87.16M
-
-

FAQ

  • What is Cosan S.A. annual EBITDA?
  • What is the all time high annual EBITDA for Cosan S.A.?
  • What is Cosan S.A. annual EBITDA year-on-year change?
  • What is Cosan S.A. quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Cosan S.A.?
  • What is Cosan S.A. quarterly EBITDA year-on-year change?
  • What is Cosan S.A. TTM EBITDA?
  • What is the all time high TTM EBITDA for Cosan S.A.?
  • What is Cosan S.A. TTM EBITDA year-on-year change?

What is Cosan S.A. annual EBITDA?

The current annual EBITDA of CSAN is $1.08B

What is the all time high annual EBITDA for Cosan S.A.?

Cosan S.A. all-time high annual EBITDA is $3.13B

What is Cosan S.A. annual EBITDA year-on-year change?

Over the past year, CSAN annual EBITDA has changed by -$1.75B (-61.97%)

What is Cosan S.A. quarterly EBITDA?

The current quarterly EBITDA of CSAN is $605.42M

What is the all time high quarterly EBITDA for Cosan S.A.?

Cosan S.A. all-time high quarterly EBITDA is $634.30M

What is Cosan S.A. quarterly EBITDA year-on-year change?

Over the past year, CSAN quarterly EBITDA has changed by +$371.12M (+158.39%)

What is Cosan S.A. TTM EBITDA?

The current TTM EBITDA of CSAN is $2.11B

What is the all time high TTM EBITDA for Cosan S.A.?

Cosan S.A. all-time high TTM EBITDA is $2.20B

What is Cosan S.A. TTM EBITDA year-on-year change?

Over the past year, CSAN TTM EBITDA has changed by +$239.20M (+12.76%)
On this page